Sequencing of SLC26A2 alleles in the infant identified two compound heterozygous mutations, p.Arg178Ter and p.Arg279Trp, of paternal and maternal origin, respectively. At request from the parents, PGD was developed by haplotype mapping of parental SLC26A2 alleles in eleven five-day embryos. Transference to the mother was attempted twice, finally resulting in pregnancy and delivery of a healthy baby. This exemplifies the utility of PGD for inherited lethal conditions with a significant risk of recurrence, and highlights the importance of accurate diagnosis of skeletal dys-* Corresponding author. E. P. Mattos et al.
Introduction
Skeletal dysplasias, or osteochondrodysplasias (OCDs), comprise a vast group of genetic diseases affecting the formation of the skeleton [1] . About 40% of OCDs can be recognized in the prenatal period [2] , and combined; OCDs are frequent malformations that significantly contribute to perinatal death [3] . An interesting group of recessive OCDs is due to mutations in the diastrophic dysplasia sulfate transporter gene (DTDST), also known as SLC26A2. Conditions with this genetic basis range from severe achondrogenesis type 1B (ACG1B) and atelosteogenesis type II (AO2), to diastrophic dysplasia (DTD), and milder recessively inherited multiple epiphyseal dysplasia (rMED) and diastrophic dysplasia variant (mDTD) [4] - [6] . ACG1B and AO2 are lethal conditions [7] , while individuals with DTD and rMED reach adult life [8] .
AO2 comprises micromelia with adducted ("hitchhiker") thumbs and talipes equinovarus with a wide gap between the first and second toes. Micrognathia, cleft palate, and small chest can also be present [9] . Shortening of tubular bones, humeri with U-or V-shaped distal ends, bowed radiuses and ulnae, and unossified pubic bones are also observed [9] . DTD usually has a similar phenotype, which may hinder the antenatal distinction between AO2 and severe DTD [8] [9] . This points to a transitional phenotype between these conditions, in which different SLC26A2 alleles contribute to a spectrum of OCDs [10] [11] .
We present a Brazilian fetus with a severe OCD diagnosed as an intermediate phenotype between AO2 and severe DTD by post mortem radiological investigation, the molecular diagnosis and subsequent preimplantation genetic diagnosis (PGD) offered to the family, leading to pregnancy and delivery of a healthy infant.
Methods

Detection of Mutations
The SLC26A2 gene was amplified by PCR and screened for the four most common SLC26A2 mutations by restriction enzyme digestion and gel electrophoresis with positive and negative controls. Subsequently, selective fragments of the gene were analyzed by bidirectional fluorescent direct sequencing. Results have been confirmed in a second amplification product. Primer sequences and restriction enzymes used are listed on Table 1.
Preimplantation Genetic Diagnosis
The established protocol followed the guidelines of the Preimplantation Genetic Diagnosis (PGD) International Society [12] . Twenty-four oocytes were fertilized and 19 embryos were successfully produced. DNA was extracted from trophectoderm cells of eleven viable embryos on the fifth day post-fertilization. All biopsied embryos were cryopreserved until transference to the mother. Whole-genome amplification was performed and samples were screened for SLC26A2 alleles by parental haplotype analysis, based on the mutations identified. As requested by the parents, 24-chromosome array-comparative genomic hybridization (aCGH) was also employed for detection of chromosomal abnormalities.
Ethical Approval
The individuals reported here were informed and consented with the anonymous disclosure of their medical information. This work was ethically reviewed and approved by the Institutional Review Board of Hospital de Clínicas de Porto Alegre.
Results
Recently, a non-consanguineous couple (32-year-old father and 30-year-old mother) of Portuguese ancestry was referred to our Institution during their second pregnancy due to recurrence of detection of a severe OCD. Their previous pregnancy ended at 16 weeks of gestation, after short fetal long bones and trunk constriction were detected. During the second pregnancy, ultrasonography identified again very short long bones and pregnancy ended at 17 weeks. Postnatal physical examination revealed a female fetus with severely shortened limbs and fingers with hitchhiker thumbs, varus deformity of lower limbs, talipes equinovarus with a wide gap between first and second toes, relative macrocephaly, midface hypoplasia, micrognathia, and short trunk (Figure 1(a) ).
Babygram showed narrowing of upper thorax, thin ribs, round ilia, and short long bones and metacarpals (Figure 1(b) ). These findings were very suggestive of either AO2 or DTD. Sequencing of the mother-father-child trio characterized the fetus as a compound heterozygote for two known pathogenic SLC26A2 point mutations, c.559C > T (p.Arg178Ter) of paternal, and c.862 C > T (p.Arg279Trp) of maternal origins (Figure 1(c) and Figure 2) . This genotype has been previously observed and associated with AO2 and DTD [9] , and the 17-week fetus presented indeed characteristic radiographic findings of both disorders.
A PGD protocol was elected by the family for a subsequent pregnancy. Upon the establishment of a PGD protocol, haplotype reconstructions identified only two embryos carrying both wild type SLC26A2 alleles ( Table 2) . These were firstly transferred to the mother, but no pregnancy developed. Of the other 9 samples, seven carried just one of the two pathogenic alleles, and only five were chromosomally balanced. The parents opted for the implantation of two heterozygous carrier embryos, and this second attempt resulted in pregnancy and delivery of a healthy infant, although the baby was not postnatally screened for SLC26A2 mutations.
Discussion
In the present study, the evaluated fetus had clinical findings compatible with both AO2 and severe DTD. In fact, the skeletal abnormalities reported here are strikingly similar to those identified in patients reported by Macías-Gomez and colleagues (2004) [10] and Maeda and colleagues [11] , who were also diagnosed with an intermediate AO2/DTD condition.
In SLC26A2, the p.Arg279Trp mutation impairs protein activity by approximately 50%, when compared to the wild-type transporter [13] . Additionally, p.Arg178Ter is the second most common mutation found in patients of the DTDST spectrum [4] . In Xenopus laevis oocytes, it was shown that p.Arg178Ter behaves almost as a null allele, practically abolishing the protein's sulfate transport activity [14] .
The substitution p.Arg279Trp has been found in AO2 mostly in compound heterozygosity with p.Arg178Ter or with another null allele [7] [10] [13] [15] , and the p.Arg178Ter + p.Arg279Trp genotype has been identified in almost half of the patients with AO2, as well as in 20% of patients with DTD diagnosed at the Lausanne Molecular Pediatrics laboratory (L. Mittaz-Crettol, personal communication). Barbosa and colleagues (2011) identified compound heterozygosity for p.Arg178Ter and p.Arg279Trp in seven Portuguese patients diagnosed with classical DTD, and commented on the phenotypic overlap due to SLC26A2 mutations [8] . Another group reported both mutations in an infant with clinical and skeletal findings suggestive of a severe variant of DTD or a mild form of AO2 [10] . These observations reinforce the notion that the same SLC26A2 mutations may not always translate into a single, characteristic phenotype, implying genetic and/or environmental factors influencing sulfate transport activity and clinical outcome.
Conclusion
This report exemplifies the growing application of PGD for severe monogenic diseases [16] . To the best of our knowledge, this is one of the first published descriptions on the application of PGD for a recessive lethal skeletal dysplasia with phenotypic characteristics between AO2 and DTD, leading to the successful live birth of a healthy infant. This exemplifies a growing trend in the medical genetics field, especially for the management of lethal recurrent Mendelian traits with substantial risk of recurrence.
